Loren Lasko

2.3k total citations
13 papers, 421 citations indexed

About

Loren Lasko is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Loren Lasko has authored 13 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Cell Biology. Recurrent topics in Loren Lasko's work include Ubiquitin and proteasome pathways (3 papers), Microtubule and mitosis dynamics (2 papers) and Quinazolinone synthesis and applications (2 papers). Loren Lasko is often cited by papers focused on Ubiquitin and proteasome pathways (3 papers), Microtubule and mitosis dynamics (2 papers) and Quinazolinone synthesis and applications (2 papers). Loren Lasko collaborates with scholars based in United States and United Kingdom. Loren Lasko's co-authors include Vincent L. Giranda, Thomas D. Penning, Saul H. Rosenberg, Xuesong Liu, Yan Shi, Joann P. Palma, Gui‐Dong Zhu, Alexander R. Shoemaker, Edward K. Han and Debra Montgomery and has published in prestigious journals such as Scientific Reports, Clinical Cancer Research and Pain.

In The Last Decade

Loren Lasko

13 papers receiving 412 citations

Peers

Loren Lasko
Les Brail United States
Steven DellaRocca United States
Mary Flanagan Quinn United States
Shashi Jatiani United States
Janice M. Mehnert United States
YT Tai United States
Nicola J. Sunter United Kingdom
Les Brail United States
Loren Lasko
Citations per year, relative to Loren Lasko Loren Lasko (= 1×) peers Les Brail

Countries citing papers authored by Loren Lasko

Since Specialization
Citations

This map shows the geographic impact of Loren Lasko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Loren Lasko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Loren Lasko more than expected).

Fields of papers citing papers by Loren Lasko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Loren Lasko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Loren Lasko. The network helps show where Loren Lasko may publish in the future.

Co-authorship network of co-authors of Loren Lasko

This figure shows the co-authorship network connecting the top 25 collaborators of Loren Lasko. A scholar is included among the top collaborators of Loren Lasko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Loren Lasko. Loren Lasko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Ji, Zhiqin, Richard F. Clark, Vikram Bhat, et al.. (2021). Discovery of spirohydantoins as selective, orally bioavailable inhibitors of p300/CBP histone acetyltransferases. Bioorganic & Medicinal Chemistry Letters. 39. 127854–127854. 16 indexed citations
2.
Mastracchio, Anthony, Chunqiu Lai, Enrico L. DiGiammarino, et al.. (2021). Discovery of a Potent and Selective Covalent p300/CBP Inhibitor. ACS Medicinal Chemistry Letters. 12(5). 726–731. 15 indexed citations
3.
Kannan, Arun, Zhi Su, Donna M. Gauvin, et al.. (2019). IL-23 induces regulatory T cell plasticity with implications for inflammatory skin diseases. Scientific Reports. 9(1). 17675–17675. 46 indexed citations
4.
Mastracchio, Anthony, Chunqiu Lai, Maricel Torrent, et al.. (2019). Investigation of biaryl heterocycles as inhibitors of Wee1 kinase. Bioorganic & Medicinal Chemistry Letters. 29(12). 1481–1486. 5 indexed citations
5.
Wang, Rui, Yupeng He, Ziping Yang, et al.. (2018). Targeting Lineage-specific MITF Pathway in Human Melanoma Cell Lines by A-485, the Selective Small-molecule Inhibitor of p300/CBP. Molecular Cancer Therapeutics. 17(12). 2543–2550. 46 indexed citations
6.
Tong, Yunsong, Maricel Torrent, Alan S. Florjancic, et al.. (2014). Pyrimidine-Based Tricyclic Molecules as Potent and Orally Efficacious Inhibitors of Wee1 Kinase. ACS Medicinal Chemistry Letters. 6(1). 58–62. 18 indexed citations
7.
Lasko, Loren, Xin Huang, Martin J. Voorbach, et al.. (2013). Multimodal assessment of nervous and immune system responses following sciatic nerve injury. Pain. 154(12). 2782–2793. 10 indexed citations
8.
Woods, Keith W., Chunqiu Lai, Julie M. Miyashiro, et al.. (2012). Aminopyrimidinone Cdc7 Kinase Inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(5). 1940–1943. 18 indexed citations
9.
Zhang, Qingwei, Michael J. Mitten, Loren Lasko, et al.. (2012). Hit to Lead optimization of a novel class of squarate-containing polo-like kinases inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(24). 7615–7622. 12 indexed citations
10.
Palma, Joann P., Yichun Wang, Luis E. Rodrı́guez, et al.. (2009). ABT-888 Confers Broad In vivo Activity in Combination with Temozolomide in Diverse Tumors. Clinical Cancer Research. 15(23). 7277–7290. 111 indexed citations
11.
Liu, Xuesong, Edward K. Han, Mark G. Anderson, et al.. (2009). Acquired Resistance to Combination Treatment with Temozolomide and ABT-888 Is Mediated by Both Base Excision Repair and Homologous Recombination DNA Repair Pathways. Molecular Cancer Research. 7(10). 1686–1692. 77 indexed citations
12.
Lasko, Loren, et al.. (2007). Chromosome Malorientations after Meiosis II Arrest Cause Nondisjunction. Molecular Biology of the Cell. 18(5). 1645–1656. 12 indexed citations
13.
Shi, Yan, Xuesong Liu, Edward K. Han, et al.. (2005). Optimal Classes of Chemotherapeutic Agents Sensitized by Specific Small-Molecule Inhibitors of Akt In Vitro and In Vivo. Neoplasia. 7(11). 992–1000. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026